Sensei Biotherapeutics, Inc.
SNSE
$7.96
$0.41395.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -24.68% | 66.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.43% | 9.83% | |||
| Operating Income | 28.43% | -9.83% | |||
| Income Before Tax | 28.09% | 11.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.09% | 11.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.09% | 11.66% | |||
| EBIT | 28.43% | -9.83% | |||
| EBITDA | 28.60% | -15.07% | |||
| EPS Basic | 28.16% | 11.75% | |||
| Normalized Basic EPS | 31.51% | -10.31% | |||
| EPS Diluted | 28.16% | 11.75% | |||
| Normalized Diluted EPS | 31.51% | -10.31% | |||
| Average Basic Shares Outstanding | 0.10% | 0.10% | |||
| Average Diluted Shares Outstanding | 0.10% | 0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||